Patient demand and politics push Herceptin forward

CMAJ. 2005 Aug 16;173(4):347-8. doi: 10.1503/cmaj.050883.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / economics
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Canada
  • Eligibility Determination
  • Female
  • Humans
  • National Health Programs / economics
  • Neoplasm Metastasis
  • Patient Participation*
  • Practice Patterns, Physicians' / statistics & numerical data
  • Receptor, ErbB-2 / analysis*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptor, ErbB-2
  • Trastuzumab